Director & CEO
Burnet Institute


Professor Brendan Crabb AC

Research Australia_Brendan Crabb

Director & CEO
Burnet Institute

Professor Brendan Crabb AC is the Director and CEO of Burnet Institute and current Chair of the Victorian chapter of the Association of Australian Medical Research Institutes (AAMRI). Professor Crabb is a molecular biologist with a particular interest in infectious diseases and in health issues of the developing world. His personal research is the development of a malaria vaccine and the identification of new treatments for this disease. He is a current member of the US-based Malaria Vaccine Science Portfolio Advisory Committee, the oversight group for the major malaria vaccines under development.

Professor Crabb holds Professorial appointments at The University of Melbourne and Monash Universities. Until his appointment as Director of the Burnet Institute he was a Senior Principal Research Fellow of the National Health & Medical Research Council of Australia, and an International Research Fellow of the US-based Howard Hughes Medical Institute.

He serves on the Scientific Advisory Boards of the Sanger Institute’s Malaria Program, the Centre for Cancer Biology UniSA & SA Pathology and the Monash Institute of Pharmaceutical Science. Professor Crabb was the Editor-in-Chief of the world’s leading parasitology research journal the International Journal for Parasitology from 2006 to 2009 and remains on its editorial board along with that of Nature Communications and F1000 Reports.

With a strong interest in education, the former lecturer in the Department of Microbiology and Immunology at The University of Melbourne is currently involved in educational and curriculum development activities for high school students and teachers through the Gene Technology Access Centre.